Johnson & Johnson (BIT:1JNJ)
133.38
-5.98 (-4.29%)
At close: May 13, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Consumer Health | - |
Log In |
Log In |
Log In |
Log In |
Consumer Health Growth | - |
Log In |
Log In |
Log In |
Log In |
Innovative Medicine | 57.28B |
Log In |
Log In |
Log In |
Log In |
Innovative Medicine Growth | 4.31% |
Log In |
Log In |
Log In |
Log In |
MedTech | 32.06B |
Log In |
Log In |
Log In |
Log In |
MedTech Growth | 4.28% |
Log In |
Log In |
Log In |
Log In |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Innovative Medicine Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
Innovative Medicine Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
MedTech Capital Expenditures |
Log In |
Log In |
Log In |
Log In |
MedTech Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
United States | 50.99B |
Log In |
Log In |
Log In |
Log In |
United States Growth | 7.84% |
Log In |
Log In |
Log In |
Log In |
Europe | 20.16B |
Log In |
Log In |
Log In |
Log In |
Europe Growth | 0.88% |
Log In |
Log In |
Log In |
Log In |
Western Hemisphere ex-US | 4.69B |
Log In |
Log In |
Log In |
Log In |
Western Hemisphere ex-US Growth | 0.43% |
Log In |
Log In |
Log In |
Log In |
Asia Pacific, Africa | 13.50B |
Log In |
Log In |
Log In |
Log In |
Asia Pacific, Africa Growth | -1.59% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 30, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Innovative Medicine Income Before Tax | 19.16B |
Log In |
Log In |
Log In |
Log In |
Innovative Medicine Income Before Tax Growth | 4.85% |
Log In |
Log In |
Log In |
Log In |
MedTech Income Before Tax | 3.64B |
Log In |
Log In |
Log In |
Log In |
MedTech Income Before Tax Growth | -6.51% |
Log In |
Log In |
Log In |
Log In |
Sales % Change due to Transactions | - |
Log In |
Log In |
Log In |
Log In |
Sales % Change due to Transactions Growth | - |
Log In |
Log In |
Log In |
Log In |
Sales % Change due to Price | - |
Log In |
Log In |
Log In |
Log In |
Sales % Change due to Price Growth | - |
Log In |
Log In |
Log In |
Log In |
Sales % Change due to Currency | - |
Log In |
Log In |
Log In |
Log In |
Sales % Change due to Currency Growth | - |
Log In |
Log In |
Log In |
Log In |